Does linezolid have a role in shortening treatment of tuberculosis?

This publication has 14 references indexed in Scilit:

• Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial
  The Lancet Infectious Diseases, 2019
• Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment
  Clinical Infectious Diseases, 2018
• The Sterilizing Effect of Intermittent Tedizolid for Pulmonary Tuberculosis
  Clinical Infectious Diseases, 2018
• Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis
  Antimicrobial Agents and Chemotherapy, 2017
• To be or not to be exclusive: the sutezolid story
  The Lancet Global Health, 2016
• Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis
  European Respiratory Journal, 2012
• Addition of PNU-100480 to First-Line Drugs Shortens the Time Needed to Cure Murine Tuberculosis
  American Journal of Respiratory and Critical Care Medicine, 2009
• Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model
  Antimicrobial Agents and Chemotherapy, 2009
• Early and Extended Early Bactericidal Activity of Linezolid in Pulmonary Tuberculosis
  American Journal of Respiratory and Critical Care Medicine, 2008
• Linezolid and rifampin: Drug interaction contrary to expectations?
  Clinical Pharmacology & Therapeutics, 2005